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OBJECTIVES: To evaluate the prevalence of cholecystopathy in chronic renal patients awaiting kidney transplants.
INTRODUCTION: The prevalence and management of cholelithiasis in renal transplant patients is not well established. 
METHODS: A total of 342 chronic renal failure patients on the waiting list for a kidney transplant were studied. Patients were 
evaluated for the presence of cholelithiasis and related symptoms, previous cholecystectomies and other abdominal surgeries, time 
on dialysis, and general data (gender, age, number of pregnancies, and body mass index).
RESULTS: Cholelithiasis was found in 41 out of 342 patients (12%). Twelve of these patients, all symptomatic, had previously 
undergone cholecystectomies. Five out of 29 patients who had not undergone surgery were symptomatic. Overall, 17 patients (41.5%) 
were symptomatic. Their mean age was 54 (range 32-74) years old; 61% were female, and their mean body mass index was 25.4. 
Nineteen (76%) out of 25 women had previously been pregnant, with an average of 3.6 pregnancies per woman.
CONCLUSIONS: The frequency of cholelithiasis was similar to that reported in the literature for the general population. However, 
the high frequency of symptomatic patients points toward an indication of routine pre-transplant cholecystectomy to avoid serious 
post-transplant complications.
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INTRODUCTION
Cholelithiasis is one of the most common gastrointestinal 
diseases. Complications due to cholelithiasis and subsequent 
hospital admissions are responsible for enhanced morbidity 
and mortality in addition to large expenses and large 
numbers of hospital beds needed by these patients. For most 
surgeons, asymptomatic lithiasis does not require surgical 
treatment, which is only required in the presence of pain or 
complications such as cholecystitis, cholangitis, jaundice 
or pancreatitis.1 However, more severe complications 
may occur in solid organ transplant patients compared 
to the normal population.2-6 The immunosuppression 
experienced by transplant patients (including the intensity 
of immunosuppression and type of immunosuppressant drug 
used) is responsible for this increase in complications.7-8 
Based on these data, some authors suggest prophylactic 
cholecystectomy in asymptomatic patients before they 
undergo transplants, thereby avoiding serious morbidity and 
increased mortality.
The purpose of this paper is to evaluate the prevalence 
of cholecystopathy in chronic renal patients awaiting kidney 
transplants.
PATIENTS AND METHODS
We retrospectively reviewed the charts of patients on the 
waiting list for kidney transplants in our unit. The analysis 
was performed until December 2007 and included 342 
patients from whom routine complete abdominal ultrasound 
results could be recovered. This ultrasound is performed on 
all patients as part of the initial evaluation before entering 
the list. We looked for the presence of gall bladder disease 
and past history of symptoms of biliary lithiasis, jaundice, 
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pancreatitis or cholecystectomy as well as previous 
abdominal surgery. We also collected general data, such as 
gender, age, body mass index, and number of pregnancies. 
When data were not available from patient charts, personal 
contact by phone was made to obtain missing data.
RESULTS
Forty-one out of 342 patients (12%) had cholelithiasis. 
Of these, 12 (29%) had a past history of cholecystectomy 
due to symptomatic cholelithiasis and 29 (71%) showed 
current lithiasis. Among the 29 patients who had not 
undergone operations, 5 were symptomatic. Overall of the 41 
patients with cholelithiasis, 17 (41.6%) were symptomatic. 
Eight patients showed signs of chronic hepatopathy, as 
shown by enhanced liver echogenicity or portal or hepatic 
vein size. Only 4 patients had undergone previous abdominal 
surgeries (appendectomies). 
Twenty-five (61%) out of the 41 above mentioned 
patients were female. Their mean age was 54 years old 
(range 32-74), and their mean body mass index was 25.4. 
Nineteen women (76%) had previously been pregnant, with 
an average of 3.6 full-term pregnancies per woman (average 
of 4.5 pregnancies when abortions were included).
DISCUSSION
Few studies in Brazil have evaluated the frequency of 
cholelithiasis. Coelho et al.9 studied 1,000 normal adults 
(who were randomly selected in shopping centers) by 
abdominal ultrasound and found a gallstone prevalence of 
9.3% (12.9% in women and 5.4% in men), with marked age-
dependent differences (2.4% of people 20-29 years of age vs. 
27.5% of people over 70 years old). Torres et al.10 studied 
500 people who had undergone an ultrasound and whose 
complaints were unrelated to the biliary system and found 
a gallstone frequency of 18.4% (20.8% in women and 16% 
in men). These data, as well as data from the international 
literature, point to a high frequency of asymptomatic 
cholelithiasis, which may remain quiescent for many years. 
Therefore, many surgeons suggest a follow-up assessment, 
indicating surgery only in symptomatic or complicated 
cases.11-14
Laparoscopic cholecystectomy is considered the gold 
standard for symptomatic uncomplicated cholelithiasis. After 
its use became widespread, laparoscopic cholecystectomy 
was shown to have a remarkably lower rate of morbidity 
and mortality compared to surgery in patients with 
complicated cholelithiasis; thus, many surgeons proposed 
laparoscopic surgery for asymptomatic patients in good 
clinical condition.15-17 This is the policy in our department. 
Cholecystectomy in asymptomatic candidates and organ 
transplant patients is also controversial.18-23 Kao et al.22 
performed an extensive review of the literature on organ 
transplantation and cholelithiasis. They emphasized a 
scarcity of data and an absence of controlled studies. These 
authors pointed out an increased prevalence of gallstones in 
cardiac patients and patients using cyclosporine (8% when 
CsA was not used compared to 22% after 2 years of use). 
They also reported no difference in diabetic versus non-
diabetic patients. The overall prevalence of gallstones in pre-
transplant (heart, lung, pancreas, and kidney) patients ranged 
widely, from 6.9% to 43.8%. In patients receiving a pancreas 
or kidney alone, the frequency was 9.9%. As the prevalence 
of gallstones in the general population is estimated to 
be 10-20%, it seems that the prevalence of gallstones in 
kidney transplant candidates is not different from that of 
the general population. However, the aggregate prevalence 
of new post-transplant (kidney and pancreas) gallstones is 
12%. Pre-transplant elective cholecystectomy in non-cardiac 
solid organ candidates leads to no enhanced morbidity or 
mortality. However, when performed in the post-transplant 
period, the risk of cholecystectomy complications rises to 
an average of 11.8% morbidity and 1.5% mortality (0% in 
one study and 6.3% in another), especially when performed 
during emergencies. Graham et al.2 evaluated 551 patients on 
a transplant waiting list (kidney and pancreas) and found a 
pre-transplant cholelithiasis prevalence of 10%. Patients who 
submitted to prophylactic pre-transplant cholecystectomy 
showed no morbidity or mortality. By contrast, 18% 
of patients who did not undergo pre-transplant surgery 
presented biliary complications and were submitted to 
urgent surgery, resulting in 14% morbidity and 7% mortality. 
Greenstein et al.23 evaluated 211 asymptomatic kidney 
transplant patients and found a cholelithiasis prevalence of 
7.11%; 87% of these patients had remained asymptomatic 
for five years. Two patients developed acute cholecystitis 
and underwent uneventful laparoscopic surgeries. They 
concluded that prophylactic cholecystectomy is not 
justified in these cases. Melvin et al.24 evaluated 662 kidney 
transplant patients; 144 (21.7%) had previous or current 
history of biliary tract symptoms or identified gallstones. 
Sixty nine (48%) out of those had undergone pre-transplant 
cholecystectomies. Fourteen patients with asymptomatic 
gallstones had been followed without surgery. Fifty four 
(37%), all symptomatic, had undergone cholecystectomy in 
the post-transplant period: 30 patients (55.5%) laparoscopic, 
20 (37%) open cholecystectomy and 2 underwent conversion 
from laparoscopic to open surgery. Six patients had minor 
surgical complications with no mortality. 
Our data showed a 12% prevalence of cholelithiasis, 
a large percentage of these patients were symptomatic 
391
CLINICS 2010;65(4):389-91 Cholelithiasis in kidney transplant waiting list
Brito ATS et al.
Copyright © 2010 CLINICS
(17-41.6%). This patient group was at risk for developing 
post-transplant surgical complications, which may become 
very serious due to immunosuppression. The purpose of this 
paper was not to study post-transplant complications due to 
cholelithiasis. However, it seems logical to perform routine 
pre-transplant cholecystectomies. These cholecystectomies 
should be accomplished through laparoscopic methods, 
which have a very low frequency of morbidity and almost no 
associated mortality. This practice would prevent potentially 
serious post-transplant complications. A multicenter 
randomized trial is recommended to establish the best way 
to deal with chronic renal failure patients with cholelithiasis.
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